NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$42.33
+0.180 (+0.427%)
At Close: May 31, 2024
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham - Markets
12:34pm, Friday, 26'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),
Aerie Pharma (AERI) Gets a Buy Rating from Needham - Markets
12:16pm, Friday, 26'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Aerie Pharma (AERI – Research Report),
Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham - Markets
01:00pm, Friday, 19'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),
Needham Maintains a Buy Rating on Aerie Pharma (AERI) - Markets
12:55pm, Friday, 19'th Jun 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report),
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
10:05am, Friday, 19'th Jun 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulator
$84.30 Million in Sales Expected for Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) This Quarter
07:14am, Monday, 15'th Jun 2020
Equities research analysts expect that Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) will post sales of $84.30 million for the current quarter, Zacks reports. Four analysts have issued estimates for Amp
Amphastar Pharmaceuticals Inc (AMPH): Hedge Funds In Wait-and-See Mode
08:17pm, Friday, 12'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
Aerie Pharma (AERI) Received its Third Buy in a Row - Markets
12:43pm, Friday, 12'th Jun 2020
After Mizuho Securities and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy,
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
10:30am, Friday, 12'th Jun 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulator
Top Pharmaceutical Stocks for Q3 2020
06:45pm, Thursday, 11'th Jun 2020
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q3 2020.
Dow Jones Today Set To Snap Win Streak, Stocks Lower As Airline Pullback: Dexcom Rallies On Price Hike
01:52pm, Tuesday, 09'th Jun 2020
Lovesac and Nikola were early risers, as airlines retreated and stock futures slipped and the Dow Jones today appeared set to snap its seven-day advance.
Amphastar’s newly approved drug product was determined by the FDA to be therapeutically equivalent to Quelicin™ (Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial)
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
08:05pm, Tuesday, 02'nd Jun 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Bill Peters, CFO and Dan Dischner, Vice President of Corporate Communications and Human Resources will be presenting at the Jefferies Virtua
